Last Updated: November 8, 2026

Details for New Drug Application (NDA): 017381

NDA 017381 describes SILVADENE, which is a drug marketed by King Pharms Llc and is included in one NDA. It is available from three suppliers. Additional details are available on the SILVADENE profile page.

The generic ingredient in SILVADENE is silver sulfadiazine. There is one drug master file entry for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the silver sulfadiazine profile page.

Summary for 017381

Tradename:	SILVADENE
Applicant:	King Pharms Llc
Ingredient:	silver sulfadiazine
Patents:	0

Pharmacology for NDA: 017381

Medical Subject Heading (MeSH) Categories for 017381

Anti-Infective Agents, Local

Suppliers and Packaging for NDA: 017381

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
SILVADENE	silver sulfadiazine	CREAM;TOPICAL	017381	NDA	A-S Medication Solutions	50090-0230	50090-0230-0	1 TUBE in 1 CARTON (50090-0230-0) / 20 g in 1 TUBE
SILVADENE	silver sulfadiazine	CREAM;TOPICAL	017381	NDA AUTHORIZED GENERIC	Mylan Pharmaceuticals Inc.	59762-0131	59762-0131-0	1 TUBE in 1 CARTON (59762-0131-0) / 20 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CREAM;TOPICAL			Strength	1%
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Expired US Patents for NDA 017381

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
King Pharms Llc	SILVADENE	silver sulfadiazine	CREAM;TOPICAL	017381-001	Approved Prior to Jan 1, 1982	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.